Trials / Completed
CompletedNCT00630214
Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection
Phase 2 Study of Routine Oral Calcium and Vitamine D Supplements to Prevent Hypocalcemia After Total Thyroidectomy in Papillary Thyroid Carcinoma Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 15 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
the increased risk of hypocalcemia following total thyroidectomy plus central neck dissection can be minimized by routine administration of oral calcium and vitamin D supplements during the early postoperative period.
Detailed description
Of patients with differentiated papillary thyroid carcinoma, group D underwent total thyroidectomy alone and groups A-C underwent total thyroidectomy plus CND. The latter were randomized to oral calcium (3 g/day) plus vitamin D (1 mcg/day) (group A, n = 49), calcium alone (group B, n = 49), or no supplements (group C, n = 50). Hypocalcemic symptoms, serum calcium, and parathyroid hormone (PTH) levels were compared among the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral calcium plus vitamin D | calcium supplementation took 3 g/day oral calcium (1 g every 8 h) plus 1 mcg/day vitamin D (0.5 mcg every 12 h), beginning on the night of surgery and continuing for 14 days. |
| DIETARY_SUPPLEMENT | Oral calcium alone | calcium carbonate (3 g/day, 1 g every 8 h) |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2008-03-06
- Last updated
- 2008-03-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00630214. Inclusion in this directory is not an endorsement.